<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>SARM Compound Library</title>
    <link rel="preconnect" href="https://fonts.googleapis.com" />
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet" />
    <style>
      :root {
        --bg: #0e0f11;
        --card: rgba(255, 255, 255, 0.04);
        --card-glow: rgba(0, 255, 204, 0.35);
        --accent: #00ffd0;
        --text: #eef3f7;
        --text-dim: #8392a7;
        --radius: 1.25rem;
        --transition: 0.6s cubic-bezier(0.19, 1, 0.22, 1);
      }
      *,*:before,*:after{box-sizing:border-box;margin:0;padding:0}
      body{font-family:"Inter",system-ui,sans-serif;background:var(--bg);color:var(--text);line-height:1.6;overflow-x:hidden}
      header{display:flex;justify-content:space-between;align-items:center;padding:1rem 1.5rem;max-width:1200px;margin:0 auto}
      a.logo{color:var(--text);font-weight:700;text-decoration:none}
      main{max-width:1200px;margin:0 auto;padding:2.5rem 1.5rem}
      h1{font-size:clamp(1.8rem,4vw,2.6rem);margin-bottom:1.75rem;position:relative}
      h1::after{content:"";position:absolute;bottom:-6px;left:0;width:64px;height:3px;background:var(--accent);border-radius:2px}
      .search-bar{width:100%;max-width:560px;margin:0 auto 2.2rem}
      .search-bar input{width:100%;padding:0.85rem 1rem;background:var(--card);border:1px solid transparent;border-radius:var(--radius);color:var(--text);font-size:1rem;transition:border 0.3s ease}
      .search-bar input:focus{outline:none;border-color:var(--accent)}
      .grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(260px,1fr));gap:1.5rem}
      .card{background:var(--card);backdrop-filter:blur(22px) saturate(160%);border:1px solid rgba(255,255,255,0.06);border-radius:var(--radius);padding:1.5rem;position:relative;overflow:hidden;transform:translateY(20px);opacity:0;transition:var(--transition);cursor:pointer}
      .card.show{transform:none;opacity:1}
      .card::before{content:"";position:absolute;inset:0;background:linear-gradient(135deg,var(--card-glow) 0%,transparent 60%);opacity:0;transition:opacity 0.4s ease}
      .card:hover::before{opacity:1}
      .card h3{font-size:1.1rem;margin-bottom:0.35rem}
      .tag{display:inline-block;font-size:0.75rem;background:var(--accent);color:#000814;padding:2px 6px;border-radius:4px;font-weight:600;margin-bottom:0.9rem}
      .card p{font-size:0.88rem;color:var(--text-dim);white-space:pre-line}
      /* modal */
      .hidden{display:none !important}
      #modal{position:fixed;inset:0;background:rgba(0,0,0,0.7);backdrop-filter:blur(4px);display:flex;justify-content:center;align-items:center;padding:1.5rem;z-index:100;opacity:0;pointer-events:none;transition:opacity 0.4s ease}
      #modal.active{opacity:1;pointer-events:all}
      .modal-content{background:var(--card);border:1px solid rgba(255,255,255,0.08);border-radius:var(--radius);max-width:540px;width:100%;padding:2rem 1.75rem;position:relative;animation:fadeUp 0.45s ease}
      @keyframes fadeUp{from{transform:translateY(40px);opacity:0}to{transform:none;opacity:1}}
      .modal-content h3{margin-bottom:0.9rem;font-size:1.5rem}
      .close-btn{position:absolute;top:1.1rem;right:1.1rem;font-size:1.3rem;background:none;border:none;color:var(--text-dim);cursor:pointer;transition:color 0.3s ease}
      .close-btn:hover{color:var(--accent)}
      /* ——— quick-wins / medium extras ——— */
#disclaimerBanner{position:fixed;bottom:0;left:0;width:100%;padding:.6rem 1rem;
  background:var(--accent,#ea3546);color:#fff;display:flex;justify-content:space-between;
  z-index:999;font-size:.9rem}
#disclaimerBanner button{all:unset;font-size:1.2rem;cursor:pointer;margin-left:.8rem}

#filterToggle{position:fixed;top:1rem;right:1rem;padding:.45rem .9rem;border:0;
  background:var(--surface-3,#222);color:#fff;border-radius:6px;box-shadow:0 2px 6px rgba(0,0,0,.2);
  cursor:pointer;z-index:999}

#filterSidebar{position:fixed;top:0;right:0;width:260px;height:100vh;overflow-y:auto;
  background:var(--surface-1,#111);color:var(--text,#e2e8f0);padding:1rem;
  box-shadow:-4px 0 12px rgba(0,0,0,.3);transform:translateX(100%);
  transition:transform .3s ease;z-index:998}
#filterSidebar.open{transform:translateX(0)}

.chip{display:inline-block;margin:.15rem .25rem .15rem 0;padding:.15rem .55rem;
  font-size:.75rem;border-radius:9999px;background:var(--surface-2,#272b30);
  color:var(--text-dim,#a0aec0);cursor:pointer;user-select:none;transition:.2s}
.chip.active{background:var(--accent,#ea3546);color:#fff}

.riskGauge{display:block;height:8px;width:100%;border-radius:4px;margin-bottom:.4rem;
  background:linear-gradient(to right,#4caf50 0%,#ffc107 calc((var(--risk)-1)*25%),#f44336 calc((var(--risk)-1)*25%))}
/* ============ FILTER-KNAPP MOBIL ============ */
@media (max-width: 480px) {
  #filterToggle .label { display: none; }
  #filterToggle       { padding: 0.5rem 0.55rem; }
}

    </style>
  </head>
  <body>
    <header>
      <a class="logo" href="index.html">← Home</a>
    </header>
    <main>
      <h1>Selectively‑Androgen Receptor Modulators (SARMs)</h1>
      <div class="search-bar"><input type="text" id="search" placeholder="Search SARMs…" /></div>
      <div class="grid" id="grid"></div>
    </main>

    <div id="modal" class="hidden" tabindex="-1"><div class="modal-content"></div></div>

    <script>
      /* ----------------------------- DATA -------------------------------- */
      const sarms = [
 // --- 1. First-generation / well-known ---------------------------------
  {
    name: "RAD-140 (Testolone)",
    dose: "10–20 mg oral daily",
    pros: "Very high anabolic : androgenic ratio; size & strength gains; bone density ↑",
    cons: "Liver-enzymes (ALT/AST) ↑; HDL ↓; full HPTA suppression at ≥10 mg",
    details: "Tricyclic non-steroidal AR agonist with ~28 h half-life; shows 40× greater AR affinity than testosterone while sparing prostate in primate data."
  },
  {
    name: "LGD-4033 (Ligandrol)",
    dose: "5–10 mg oral daily",
    pros: "Robust lean-mass & strength increase; good oral bio-availability",
    cons: "Total/Free T ↓ 55–85 % after 3 wk; HDL ↓; mild SHBG drop",
    details: "Pyrrolidine SARM (t½ ≈24 h) that added 1.5 kg LBM in a 21-day human study at only 1 mg/day."
  },
  {
    name: "MK-2866 (Ostarine, Enobosarm)",
    dose: "20–30 mg oral daily",
    pros: "Mild anabolic with joint/ligament benefit; minimal BP/lipid impact",
    cons: "HPTA suppression at >20 mg; mild ALT ↑ in some",
    details: "Phase-III cancer-cachexia drug; 12-h half-life; lowest side-effect SARM for first-time users."
  },
  {
    name: "S4 (Andarine)",
    dose: "25–50 mg oral BID (split due to 4-h t½)",
    pros: "Noticeable fat-loss hardness; strong AR binding; early contest prep favourite",
    cons: "Night-vision tint (‘yellow filter’) & light adaptation delay; LDL ↑ at high dose",
    details: "First-generation SARM originally for BPH; vision side-effect from partial agonism at retinal AR."
  },

  // --- 2. Higher-potency / 2nd-gen --------------------------------------
  {
    name: "LGD-3303",
    dose: "10–15 mg oral daily",
    pros: "Greater bone-anabolic potency than LGD-4033; may stack well with GH",
    cons: "Limited human safety data; stronger suppression than LGD-4033",
    details: "Tetrahydro-quinoline SARM whose demethylated metabolite maintains high AR affinity but minimal prostate stimulation in rat models."
  },
  {
    name: "S23",
    dose: "10–20 mg oral daily",
    pros: "Very dry, hard look; candidate male contraceptive (zero sperm in rats)",
    cons: "Severe suppression even at 10 mg; dark-brown urine possible; aggression spikes",
    details: "Diaryl-propionamide SARM with AR-binding KD ≈1.7 nM (stronger than RAD-140); increases FSH/LH suppression dose-dependently."
  },
  {
    name: "AC-262536",
    dose: "15–30 mg oral daily",
    pros: "Lean mass with *minimal* prostate weight gain; mild lipid impact",
    cons: "Modest overall gains; short t½ (~6 h) → BID ideal",
    details: "Indole-based partial agonist (60 % of DHT’s anabolic activity) engineered for osteoporosis but never advanced past animals."
  },
  {
    name: "LGD-2226",
    dose: "10–20 mg oral daily",
    pros: "Long half-life (~13 h); good muscle retention during calorie deficit",
    cons: "Not commercially available; preclinical only; liver enzymes ↑ in dogs",
    details: "Triazolopyrimidine SARM with strong AR selectivity and 46 % oral bio-availability in canines."
  },
  {
    name: "TLB-150 (RAD-150, Testolone-Benzoate)",
    dose: "20–40 mg oral daily",
    pros: "Esterified RAD-140 → longer half-life & steadier levels; less frequent dosing",
    cons: "No formal toxicology; same liver/lipid issues as RAD; more expensive",
    details: "Benzoate-ester prodrug hydrolyses in vivo to RAD-140, delivering a slower release curve similar to a short injectable ester."
  },

  // --- 3. Myostatin & hybrid agents ------------------------------------
  {
    name: "YK-11",
    dose: "5–10 mg oral daily",
    pros: "Up-regulates follistatin → myostatin blockade; very dry lean-mass look",
    cons: "Steroidal structure means liver strain; scant human research; suppression",
    details: "19-nor steroid that is a partial AR agonist and potent SMAD3 antagonist—combining SARM-like lean gains with myostatin inhibition."
  },

  // --- 4. Endurance / metabolic “SARM-adjacent” -------------------------
  {
    name: "GW-501516 (Cardarine)",
    dose: "10–20 mg oral daily",
    pros: "Endurance ↑; fatty-acid oxidation; HDL ↑, TG ↓",
    cons: "High-dose rodent studies showed rapid GI tumour formation; WADA ban",
    details: "Selective PPAR-δ agonist that up-regulates CPT-1 and oxidative type-I muscle fibers — *not* an AR modulator."
  },
  {
    name: "SR9009 (Stenabolic)",
    dose: "20–30 mg oral daily (split q4h)",
    pros: "Increases basal metabolism & wakefulness; clock-gene alignment",
    cons: "Very poor oral bio-availability; needs frequent dosing; efficacy debated",
    details: "REV-ERBα/β agonist that boosts mitochondria count and shifts substrate usage toward lipids in mouse studies."
  },
  {
    name: "MK-677 (Ibutamoren)",
    dose: "10–25 mg oral nightly",
    pros: "GH/IGF-1 ↑ 40–70 %; deeper REM sleep; joint healing support",
    cons: "Water retention & appetite surge; mild insulin resistance; numb hands (CTS-like)",
    details: "Non-peptide ghrelin mimetic (GHSR-1a agonist) that raises GH pulsatility for 24 h—often stacked with SARMs for synergistic growth."
  }
      ];

      /* --------------------- INIT --------------------------- */
      const grid = document.getElementById("grid");
      const searchInput = document.getElementById("search");

      const createCard = (c) => {
        const card = document.createElement("div");
        card.className = "card";
        card.dataset.name = c.name.toLowerCase();
        card.innerHTML = `
          <span class="tag">${c.dose}</span>
          <h3>${c.name}</h3>
          <p><strong>Pros:</strong>\n${c.pros}</p>
          <p style="margin-top:0.6rem"><strong>Cons:</strong>\n${c.cons}</p>
        `;
        card.addEventListener("click", () => openModal(c));
        return card;
      };

      const render = () => {
        sarms.forEach((c) => grid.appendChild(createCard(c)));
        document.querySelectorAll(".card").forEach((el) => observer.observe(el));
      };

      /* ---------------- SEARCH ---------------- */
      searchInput.addEventListener("input", (e) => {
        const q = e.target.value.toLowerCase();
        grid.querySelectorAll(".card").forEach((card) => {
          card.style.display = card.dataset.name.includes(q) ? "block" : "none";
        });
      });

      /* ---------------- MODAL ---------------- */
      const modal = document.getElementById("modal");
      const modalContent = modal.querySelector(".modal-content");
      const openModal = (compound) => {
        modalContent.innerHTML = `
          <button class="close-btn" aria-label="Close modal">×</button>
          <h3>${compound.name}</h3>
          <p><strong>Standard Dose:</strong> ${compound.dose}</p>
          <p style="margin-top:0.9rem;white-space:pre-line;"><strong>Pros:</strong>\n${compound.pros}</p>
          <p style="margin-top:0.9rem;white-space:pre-line;"><strong>Cons:</strong>\n${compound.cons}</p>
        `;
        modal.classList.add("active");
        modal.classList.remove("hidden");
        modalContent.querySelector(".close-btn").addEventListener("click", closeModal);
      };
      const closeModal = () => {
        modal.classList.remove("active");
        setTimeout(() => modal.classList.add("hidden"), 300);
      };
      modal.addEventListener("click", (e) => { if (e.target === modal) closeModal(); });
      document.addEventListener("keydown", (e) => { if (e.key === "Escape" && modal.classList.contains("active")) closeModal(); });

      /* -------------- Scroll Reveal ------------- */
      const observer = new IntersectionObserver((entries, obs) => {
        entries.forEach((entry) => {
          if (!entry.isIntersecting) return;
          entry.target.classList.add("show");
          obs.unobserve(entry.target);
        });
      }, {threshold:0.15});

      render();
    </script>
    <script src="enhancements.js" defer></script>

  </body>
</html>
